Blood Sugar Management in Geriatric Patients

Health Status-Based Targets

The American Diabetes Association recommends HbA1c goals of <7.0-7.5% for healthy older adults with intact function, <8.0% for those with multiple comorbidities or mild-to-moderate cognitive impairment, and avoidance of reliance on HbA1c entirely for frail patients with poor health, instead targeting avoidance of symptomatic hyperglycemia and hypoglycemia 1
For healthy older adults, the American Diabetes Association suggests fasting/preprandial glucose targets of 80-130 mg/dL and bedtime glucose targets of 80-180 mg/dL 3
The American Geriatrics Society recommends that comorbidities and cognitive impairment be considered when determining HbA1c targets, with a goal of <8.0% for those with multiple comorbidities or mild-to-moderate cognitive impairment 1, 2, 3

The American Diabetes Association advises against targeting HbA1c <6.5% in elderly patients, as this increases mortality risk without clinical benefit, and instead recommends individualized targets based on health status and functional ability 5
The Journal of the American Geriatrics Society recommends avoiding aggressive control (HbA1c <7%) in frail elderly, as the risks of hypoglycemia outweigh potential benefits 4

The American Geriatrics Society recommends metformin and DPP-4 inhibitors as preferred medications for elderly patients due to lower hypoglycemia risk, and advises against the use of sulfonylureas when possible 4
The American Diabetes Association suggests GLP-1 receptor agonists as suitable third-line agents, providing 1-2% HbA1c reduction with weight loss benefits and low hypoglycemia risk 8